1 / 39

Salivary Gland Disorders

Salivary Gland Disorders. Salivary Gland Disorders ENT for the PA-C. Andrew Golde MD,CM FRCSC FACS Advanced Ear, Nose and Throat Associates Atlanta, GA February 2011. Classification of Salivary Disorders. Infections Systemic disorders Trauma Medication side-effects Neoplasms.

chelsia
Download Presentation

Salivary Gland Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Salivary Gland Disorders

  2. Salivary Gland DisordersENT for the PA-C Andrew Golde MD,CM FRCSC FACS Advanced Ear, Nose and Throat Associates Atlanta, GA February 2011

  3. Classification of Salivary Disorders • Infections • Systemic disorders • Trauma • Medication side-effects • Neoplasms

  4. Salivary Gland Anatomy • Major salivary glands • Parotid (2) • Submandibular (2) • Sublingual (2) • Minor salivary glands (5000)

  5. Salivary Gland Physiology • Autonomic control • Parasympathetic ---> secretion (Ach) • Sympathetic ---> composition (adrenergic) • Complex composition • Electrolytes, urea, ammonia, glucose, cholesterol, fatty acids, lipids, amino acids, proteins (albumin, globulin, enzymes, glycoproteins, polypeptides including kallikrein, epidermal growth factor, renin, glucagon, angiotensin II, erythropoetin, gastrin, somatostatin)

  6. Functions of Saliva • Lubricant • Aid swallowing, mechanical cleaning • Digestion • Enzymatic cleavage - amylase • Mediation of taste • Excretion • Blood group proteins, mediators, viruses • Defense • Antibodies, mucosal integrity

  7. Saliva Production • Max rate 1 ml/min/gm of tissue • High blood flow (10x equal mass muscle) • Distribution • Parotid 75% low viscosity • Submandib 20% medium • Minor 5% high

  8. Take Home Message • Three categories of problems • 1. Altered saliva production • 2. Painless swelling of saliva glands • 3. Painful swelling of saliva glands

  9. Disorders of Altered Physiology • Increased or decreased stimulation • Medication, neurogenic, hormonal • Obstruction of secretion • Sialadenitis, sialolithiasis • Change of composition • Cystic fibrosis • Nutrition • Parenchymal damage • Irradiation, Sjogren’s syndrome, cystic fibrosis

  10. Sialadenosis • Recurrent painless swelling (parotid) • Etiology • Endocrine disorders (diabetes) • Malnutrition (protein, ETOH, vitamin) • Autonomic dysfunction • Treatment • Correct underlying causes • Reassurance

  11. Sialolithiasis • Formation of salivary stones • Submandibular (92%) > Parotid (6%) > Minor (2%) • High mucin content, Alkaline pH, high concentration organic matter and Ca and salts • Anatomy of Wharton’s duct • One of most common causes of salivary dysfunction

  12. Sialolithiasis • Etiology • Enhanced in presence of stasis of salivary flow • Genetic predisposition (kidney stones, gout) • Mineralization of a mucoid gel • Clinical Presentation • Asymptomatic • Recurrent swelling associated with eating • Spitting out stones • Sialadenitis (infection)

  13. Sialolithiasis • Management • Hydration • Massage (Post --->Ant) + heat • Anti-inflamatories • Antibiotics if infected • Removal of stones • Sialendoscopy • Surgical excision of affected gland

  14. Disorders of Decreased Saliva • Irradiation • Sjogren’s syndrome • Cystic fibrosis • Anti-cholinergic side effects of meds

  15. Irradiation of Salivary Glands • Conventional XRT for head and neck tumors 6000-7000cGy over 6-7 weeks • 50% function lost after 1000 cGy • 90-100% loss after complete course of XRT • Xerostomia can last for several years • Loss of taste • Increased incidence dental carries • Altered nutritional status • Loss of appetite

  16. Irradiation of Salivary Glands • Protective strategies • IMRT (Intensity modulated radiation therapy) • Lower total doses (Canada vs US) • Amifostine • Free oxygen radical scavenger • Difficult to tolerate • Treatment • Supportive - H2O, lubricants • Salivary promoting drugs

  17. Sjogren’s Syndrome • Autoimmune disease of major and minor salivary, lacrimal, mucous and sweat glands • 1933 Sjogren original description • Keratoconjunctivitis sicca • Xerostomia • Rheumatoid arthritis (scleroderma, mixed connective tissue disease, polyarteritis nodosa, polymyositis, SLE) • Classification • Primary - Sjogren’s syndrome alone • Secondary - Sjogren’s plus other autoimmune

  18. Sjogren’s Syndrome • Diagnosis • Lower lip minor salivary gland biopsy • Dense lymphocytic infiltrate/plasma cells • Sjogren’s autoantibodies • Positive Rheumatoid factor • Elevated C-reactive protein • High titers IgA, IgG, IgM • Demographics • Female >> male • Middle age

  19. Sjogren’s Syndrome • Treatment • Artificial lubricants for ocular, nasal and oral dryness • Salivary stimulants (Evoxac) • Immunosuppressants (Plaquenil, MTX, Humara) • Predisposition to Non-Hodgkin’s lymphoma • Parotid gland mass enlarging (painless) • MALToma

  20. PAINLESS Sialadenosis Sialolithiasis Sjogren’s HIV Granulomatous Benign primary tumors Lymphoma PAINFUL Bacterial sialadenitis Mumps Malignant primary tumors Swelling of Saliva Glands

  21. Salivary Infections • Primary bacterial (sialadenitis) • Secondary viral • Granulomatous

  22. Sialadenitis • Bacterial infections of salivary glands • Mechanical blockage of salivary ducts or reduced production of saliva • Retrograde contamination by oral cavity flora • Classification • Acute • Recurrent • Chronic

  23. Acute Sialadenitis • All glands - parotid most frequent • Contributing factors • Stasis; immunocompromise; poor oral hygiene • Post-op • Dehydration • Anti-cholinergics or diuretics • Rapid onset pain, swelling, induration • Suppurative discharge from duct • S.aureus, S. pyogenes, S. viridans, S. pneumoniae, H. flu

  24. Acute Sialadenitis • Treatment • B-lactam resistant penicillin or cephalosporin • Augmentin, Clindamycin • Steroids • Fluid replacement • Sialogogues • Analgesics • Manual massage • Topical heat

  25. Recurrent Sialadenitis • Mechanical obstruction most common factor • CT scan of neck with contrast to rule out stones or intrinsic lesions or abscess pockets • Oral anaerobes prominent • Clindamycin, Augmentin, Flagyl + ceph, Avelox • Surgical excision of gland as last resort

  26. Chronic Sialadenitis • Usually follows recurrent infections • Permanent alteration of gland architecture • Surgical excision required

  27. Acute Sialadenitis • Complications include abscess • Persistent symptoms > 4 days of Rx • Uni or multiloculated • CT scan of neck with contrast • Sialography contraindicated • Surgical drainage

  28. Secondary Viral Infections • Hematogenous dissemination • Mumps • HIV

  29. Mumps • Single most common cause of acute nonsuppurative sialadenitis in childhood • Bilateral parotid swelling (+++) • Rarely submandibular • Pain exacerbated by eating • Paramyxovirus • Highly contagious - airborne droplets • Incubation 18 days • MMR vaccination

  30. Mumps • Diagnosis is clinical • Hemagglutination inhibition or complement fixation • Elevated serum salivary type amylase • Viremia abates in 7 days • Gland swelling abates in weeks • Hydration and rest • Severe cases • Meningoencephalitis, orchitis, pancreatitis, nephritis • Other viruses rarely mimic • Parainfluenza, coxsackie, echovirus, EBV

  31. HIV Infection • HIV-SGD: HIV-associated salivary gland disease • Parotid glands most commonly affected • Gradual painless cystic enlargement • Xerostomia, xerophthalmia, arthralgias • Cysts up to several cm in size • Originate within lymph nodes • 10% coexistence of lymphoma • CT scan and FNA if suspicious • Surgical excision if considering lymphoma diagnosis

  32. Granulomatous Infections • Not uncommon • Painless gradual enlargement of isolated mass in gland • DDX includes neoplasm • Etiology • Typical and atypical TB • Actinomycosis • Cat scratch • Toxoplasmosis • Tularemia • CT scan, FNA, serology

  33. Salivary Gland Tumors Benign vs. Malignant Neoplasms

  34. BENIGN Painless Slow growing Facial nerve intact More common MALIGNANT Can be painful Growing rapidly Facial nerve can become paralyzed Lymphadenopathy Less common Salivary Gland Tumors

  35. Location of Gland Parotid Submandibular Minor Incidence of Malignancy 20% 50% 80% Salivary Gland Tumors

  36. Benign Salivary Tumors • Adenomas • Pleomorphic • Monomorphic • Wathin’s tumor • Oncocytoma • Oncocytic papillary cystadenoma • Myoepithelioma • Sialadenoma • Inverted ductal papilloma • Hemangioma • Lymphangioma

  37. LOW GRADE Mucoepidermoid ca Acinic cell ca Adenocarcinoma HIGH GRADE Mucoepidermoid ca Adenoid cystic ca Adenocarcinoma Carcinoma ex pleomorphic Squamous cell ca Undifferentiated ca Malignant Salivary Tumors

  38. Factors Influencing Survival • Histopathologic diagnosis • Lymph node metastasis • Pain • Facial nerve paralysis • Skin involvement • Stage • Location • Recurrence • Distant metastases

  39. Evaluation of Suspected Tumors • FNA • CT scan of neck with contrast • Surgery for frozen section analysis

More Related